GS vs ISRG: Which Is the Better Buy?

Side-by-side comparison of The Goldman Sachs Group, Inc. and Intuitive Surgical, Inc. β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-04-22.
The Goldman Sachs Group, Inc. Β· Financial Services
$907.80
-3.1% upside to fair value
Low Conviction Grade C+
VS
Intuitive Surgical, Inc. Β· Healthcare
$451.29
+130.4% upside to fair value
Grade B High Quality
QuantHub Verdict
ISRG has more upside to fair value (+130.4%). GS trades at a lower forward P/E (15.6x). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric GS ISRG
Current Price $907.80 $451.29
Fair Value Estimate $880.00 $1,039.74
Upside to Fair Value -3.1% +130.4%
Market Cap $269.4B $160.3B
Forward P/E 15.6x 53.8x
EV / EBITDA 29.7x 40.5x
Price / Sales 2.1x 15.2x
Price / FCF β€” 64.3x
Revenue Growth YoY +9.0% +23.0%
Gross Margin 47.5% 66.3%
Operating Margin 17.5% 30.5%
Return on Equity 13.8% 17.0%
Dividend Yield 1.71% 0%
FCF Yield β€” 1.55%
Analyst Consensus Buy Strong Buy
Investment Thesis
GS β€” The Goldman Sachs Group, Inc.
Goldman Sachs remains the premier global investment bank with dominant franchises in M&A advisory, equities trading, and asset management. FY2025 delivered $58.3B net revenues, 15% ROE, and $51.32 diluted EPS, powered by record equities trading and a resurgent IB pipeline. The stock has pulled back 8% from January highs near $985 but still trades at 2.27x book value, well above the 5-year median …
ISRG β€” Intuitive Surgical, Inc.
Intuitive Surgical, Inc. is a leading healthcare company specializing in robotic-assisted surgery through its flagship da Vinci system, which has established a durable competitive moat with approximately 10,000 systems installed globally and nearly 17 million procedures performed by the end of 2024. The company benefits from a high-quality business model characterized by 85% recurring revenue, st…
Accumulation Zones
Metric GS ISRG
Zone Low $600.00 $779.81
Zone High $680.00 $883.78
In Buy Zone? No Yes
← GS Research    ISRG Research β†’    All Research